The Bedside Ten: rising researchers to watch this year
Our annual list of early-career scientists and clinicians doing work that deserves attention, picked from 600 nominations by our reporters and a panel of senior researchers.
Our annual list of early-career scientists and clinicians doing work that deserves attention, picked from 600 nominations by our reporters and a panel of senior researchers.
A national survey of 1,200 local health departments found that one in three lost an epidemiologist last year. Fewer than half filled the job.
The number of drugs in short supply has fallen for the first time in three years. But sterile injectables used in ERs and operating rooms make up a growing share.
The instructions we hand patients on the way out the door are written for lawyers and billing departments. We can do better, and it would not cost much.
A new payment rule will cover home devices that track heart failure patients between visits. Doctors like the idea and worry about who reads the data.
Tessellate Bio says its benchtop system could cut the cost of making some gene therapies by 80 percent. It has raised $46 million to prove it.
A long study linked years of night shifts to earlier joint problems in nurses. Here is how to read it, from a doctor who has worked a lot of nights.
With the nearest primary care clinic an hour away, a pharmacy in western Kansas now checks blood pressure, adjusts diabetes medicines and refers patients on.
Two of the three companies that make clorvatine stopped production this summer. The third cannot keep up, and patients are being switched to other drugs.
At least 11 states are weighing bills on software that listens to doctor visits and writes the notes. Most would require patients to be told, and some to say yes.
